PDS Biotechnology
PDSB
PDSB
55 hedge funds and large institutions have $9.9M invested in PDS Biotechnology in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.82% less ownership
Funds ownership: 18.12% → 16.3% (-1.8%)
Holders
55
Holding in Top 10
–
Calls
$234K
Puts
–
Top Buyers
| 1 | +$599K | |
| 2 | +$396K | |
| 3 | +$338K | |
| 4 |
Renaissance Technologies
New York
|
+$144K |
| 5 |
Squarepoint
New York
|
+$133K |
Top Sellers
| 1 | -$2.96M | |
| 2 | -$89.3K | |
| 3 | -$35.7K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$27.1K |
| 5 |
RWM
Ritholtz Wealth Management
New York
|
-$23.4K |